GoodRx Holdings [GDRX] vs Veeva Systems [VEEV] Detailed Stock Comparison
GoodRx Holdings
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: GoodRx Holdings wins in 7 metrics, Veeva Systems wins in 12 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | GoodRx Holdings | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 50.33 | 60.84 | GoodRx Holdings |
| Price-to-Book Ratio | 2.46 | 7.31 | GoodRx Holdings |
| Debt-to-Equity Ratio | 85.15 | 1.29 | Veeva Systems |
| PEG Ratio | 0.50 | 3.79 | GoodRx Holdings |
| EV/EBITDA | 13.67 | 48.57 | GoodRx Holdings |
| Profit Margin (TTM) | 4.33% | 27.29% | Veeva Systems |
| Operating Margin (TTM) | 13.20% | 28.71% | Veeva Systems |
| EBITDA Margin (TTM) | 13.20% | 28.71% | Veeva Systems |
| Return on Equity | 5.27% | 13.70% | Veeva Systems |
| Return on Assets (TTM) | 5.08% | 7.24% | Veeva Systems |
| Free Cash Flow (TTM) | $113.55M | $1.09B | Veeva Systems |
| 1-Year Return | -36.11% | 44.76% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 1.97 | 16.36 | GoodRx Holdings |
| Enterprise Value | $1.84B | $42.24B | Veeva Systems |
| EV/Revenue Ratio | 2.30 | 14.23 | GoodRx Holdings |
| Gross Profit Margin (TTM) | 93.43% | 75.26% | GoodRx Holdings |
| Revenue per Share (TTM) | $2 | $18 | Veeva Systems |
| Earnings per Share (Diluted) | $0.09 | $4.87 | Veeva Systems |
| Beta (Stock Volatility) | 1.23 | 0.98 | Veeva Systems |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
GoodRx Holdings vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| GoodRx Holdings | 1.10% | 12.13% | 5.59% | -3.82% | 5.59% | -0.66% |
| Veeva Systems | 1.17% | 2.07% | 9.35% | 4.22% | 33.77% | 40.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| GoodRx Holdings | -36.11% | -8.85% | -91.55% | -91.30% | -91.30% | -91.30% |
| Veeva Systems | 44.76% | 78.66% | 0.73% | 1,049.26% | 567.45% | 567.45% |
News Based Sentiment: GoodRx Holdings vs Veeva Systems
GoodRx Holdings
News based Sentiment: MIXED
October was a pivotal month for GoodRx, marked by a significant stock surge due to potential partnerships, but tempered by earnings misses, analyst caution, and insider selling. The company's future hinges on successfully navigating these competing forces and capitalizing on new opportunities while mitigating existing risks.
Veeva Systems
News based Sentiment: MIXED
October presented a mixed picture for Veeva, with strong financial results and growing industry adoption offset by notable insider selling and a rating downgrade. The upcoming Investor Day will be critical for clarifying the company's strategy and addressing investor concerns, making this a significant month for the investment story.
Performance & Financial Health Analysis: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.57B | $48.56B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 5,292,330 | 1,277,350 |
| 90 Day Avg. Volume | 3,495,567 | 1,488,867 |
| Last Close | $4.58 | $299.76 |
| 52 Week Range | $3.31 - $7.20 | $200.30 - $303.47 |
| % from 52W High | -36.43% | -1.22% |
| All-Time High | $64.22 (Sep 28, 2020) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -92.87% | -12.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.17% |
| Quarterly Earnings Growth | 0.92% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.27% |
| Operating Margin (TTM) | 0.13% | 0.29% |
| Return on Equity (TTM) | 0.05% | 0.14% |
| Debt to Equity (MRQ) | 85.15 | 1.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.84 | $40.51 |
| Cash per Share (MRQ) | $0.81 | $39.07 |
| Operating Cash Flow (TTM) | $190.60M | $1.35B |
| Levered Free Cash Flow (TTM) | $124.38M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 50.33 | 60.84 |
| Forward P/E | 11.05 | 43.83 |
| PEG Ratio | 0.50 | 3.79 |
| Price to Sales (TTM) | 1.97 | 16.36 |
| Price to Book (MRQ) | 2.46 | 7.31 |
| Market Capitalization | ||
| Market Capitalization | $1.57B | $48.56B |
| Enterprise Value | $1.84B | $42.24B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.30 | 14.23 |
| Enterprise to EBITDA | 13.67 | 48.57 |
| Risk & Other Metrics | ||
| Beta | 1.23 | 0.98 |
| Book Value per Share (MRQ) | $1.84 | $40.51 |
Financial Statements Comparison: GoodRx Holdings vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Revenue/Sales | $202.97M | $759.04M |
| Cost of Goods Sold | $13.36M | $173.82M |
| Gross Profit | $189.61M | $585.22M |
| Research & Development | $31.14M | $184.03M |
| Operating Income (EBIT) | $23.38M | $233.73M |
| EBITDA | $48.22M | $243.55M |
| Pre-Tax Income | $16.67M | $298.82M |
| Income Tax | $5.62M | $70.63M |
| Net Income (Profit) | $11.05M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Cash & Equivalents | $300.98M | $1.96B |
| Total Current Assets | $540.21M | $6.71B |
| Total Current Liabilities | $103.38M | $1.46B |
| Long-Term Debt | $530.63M | $66.57M |
| Total Shareholders Equity | $654.35M | $6.21B |
| Retained Earnings | $-1.43B | $3.68B |
| Property, Plant & Equipment | $34.41M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Operating Cash Flow | $37.57M | $810.54M |
| Capital Expenditures | $-142,000 | N/A |
| Free Cash Flow | $-12.46M | $877.16M |
| Debt Repayment | $-1.25M | N/A |
| Common Stock Repurchase | $-99.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GDRX | VEEV |
|---|---|---|
| Shares Short | 5.59M | 5.41M |
| Short Ratio | 0.97 | 3.60 |
| Short % of Float | 0.06% | 0.04% |
| Average Daily Volume (10 Day) | 5,292,330 | 1,277,350 |
| Average Daily Volume (90 Day) | 3,495,567 | 1,488,867 |
| Shares Outstanding | 382.82M | 162.58M |
| Float Shares | 86.43M | 150.41M |
| % Held by Insiders | 0.13% | 0.09% |
| % Held by Institutions | 0.62% | 0.89% |
Dividend Analysis & Yield Comparison: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |